Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11117886 Methods and intermediates for preparing therapeutic compounds

Patent 11117886 was granted and assigned to Gilead Sciences on September, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Gilead Sciences
Gilead Sciences
0
Date Filed
May 8, 2020
0
Date of Patent
September 14, 2021
0
Patent Applicant
Gilead Sciences
Gilead Sciences
0
Patent Application Number
20200508
0
Patent Citations Received
‌
US Patent 11267801 Therapeutic compounds
0
‌
US Patent 11787825 Therapeutic compounds for HIV virus infection
‌
US Patent 11944611 Capsid inhibitors for the treatment of HIV
0
‌
US Patent 11993583 Therapeutic compounds
0
‌
US Patent 12077537 Capsid inhibitors for the treatment of HIV
0
‌
US Patent 11685728 Capsid inhibitors for the prevention of HIV
0
‌
US Patent 11680064 Capsid inhibitors for the treatment of HIV
0
‌
US Patent 11760746 Methods and intermediates for preparing therapeutic compounds
‌
US Patent 11267799 Solid forms of an HIV capsid inhibitor
‌
US Patent 12084467 Therapeutic compounds for HIV virus infection
0
•••
Patent Inventor Names
Anna Michelle Wagner
0
Amanda Lynn Vandehey
0
Bing Shi
0
Brian Michael O'Keefe
0
Gediminas Brizgys
0
Jennifer R. Zhang
0
Scott Alan Wolckenhauer
0
Trevor James Rainey
0
Vinh Xuan Ngo
0
Winston C. Tse
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11117886
0

Find more entities like US Patent 11117886 Methods and intermediates for preparing therapeutic compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.